Back to search
Life Threatening Bleeding
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Life Threatening Bleeding trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Life Threatening Bleeding trials you may qualify forThis survey will be conducted to investigate the status of occurrence of the safety specifications set for "Safety specification" in patients who received Ondex…
The purpose of this study is to characterize andexanet posology and interaction between andexanet and enoxaparin post infusion in healthy participants.
The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood tr…
Life-threatening mass effect (LTME) arises when brain swelling displaces or compresses crucial midline structures subsequent to acute brain injuries (ABIs) like…
Background: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without…
WATCHMAN FLX™ CT is a prospective, single-arm, single-center, post-market investigation to assess device tissue coverage in subjects with non-valvular atrial fi…
Background Maternal mortality rates in many low-income countries (LMICs) remain high. The most prominent cause is bleeding after birth, called postpartum haemor…
This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in patients who…